GlassScriptPhysician profile
Hang Trinh
NPI 1336510908
$10,507.22
in general payments reported to CMS, 2019-2025
38 companies · $2,627 in 2025
The $2,627 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,728 · 2022: $710 · 2023: $3,719 · 2024: $1,723 · 2025: $2,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,193 · Travel and Lodging: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,193.21 |
| Travel and Lodging | $876.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,125.94 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Vanta Adaptivestim |
| Relievant Medsystems, INC. | $1,507.05 | 2023 | Intracept |
| Abbvie INC. | $1,010.74 | 2021-2025 | |
| Abbott Laboratories | $942.60 | 2022-2025 | Proclaim, Freestyle Libre 3 |
| Boston Scientific Corporation | $508.55 | 2021-2025 | General - Therapies, Intracept, General - Pain Management |
| Si-Bone, INC. | $316.97 | 2021-2025 | |
| Pfizer INC. | $278.44 | 2023-2025 | |
| Biohaven Pharmaceuticals, INC. | $252.43 | 2021 | |
| Collegium Pharmaceutical, INC. | $225.19 | 2021-2025 | Xtampza |
| Astrazeneca Pharmaceuticals LP | $190.30 | 2023-2024 | Airsupra, Tezspire |
| Globus Medical, INC. | $172.33 | 2025 | Senza |
| Saluda Medical Americas, INC. | $170.44 | 2025 | Evoke |
| Inspire Medical Systems, INC. | $158.52 | 2023-2024 | Inspire |
| Mml US, INC. | $145.30 | 2024 | Reactiv8 |
| Dexcom, INC. | $143.39 | 2025 | Dexcom G6 Transmitter |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hang Trinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.